Versions Compared

Old Version 6

changes.mady.by.user April Seaward

Saved on

compared with

New Version Current

changes.mady.by.user April Seaward

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Russell, C., Lange, S., Kouyoumdjian, F., Butler, A. & Ali, F. 2022. Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA? Harm Reduct J, 19(1):89.

Russell, C., Law, J., Bonn, M., Rehm, J. & Ali, F. 2022. The increase in benzodiazepine-laced drugs and related risks in canada: The urgent need for effective and sustainable solutions. Int J Drug Policy, 111:103933.

Russell, C., Nafeh, F., Pang, M., MacDonald, S.F., Derkzen, D., Rehm, J. & Fischer, B. 2022. Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study. BMC Public Health, 22(1):436.

Russell, C., Pang, M., Nafeh, F., Farrell Macdonald, S., Derkzen, D., Rehm, J. & Fischer, B. 2022. Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada. Int J Qual Stud Health Well-being, 17(1):2094111.

Ali, F., Russell, C., Nafeh, F., Chaufan, C., Imtiaz, S., Rehm, J., Spafford, A. & Elton-Marshall, T. 2022. Youth substance use service provider's perspectives on use and service access in Ontario: Time to reframe the discourse. Subst Abuse Treat Prev Policy, 17(1):9.